Palliative sedation for terminally ill cancer patients in a tertiary cancer center in Shanghai, China

详细信息    查看全文

• 作者：Xiaoli Gu ; Wenwu Cheng ; Menglei Chen ; Minghui Liu ; Zhe Zhang
• 关键词：Palliative sedation ; Terminally ill cancer patients ; Survival ; End of life ; Symptom management ; Agitated delirium
• 刊名：BMC Palliative Care
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：14
• 期：1
• 全文大小：342 KB
• 参考文献：1. Howland, J (2005) Questions about palliative sedation: An act of mercy or mercy killing?. Ethics Medics 30: pp. 1-2
  2. Maltoni, M, Scarpi, E, Rosati, M, Derni, S, Fabbri, L, Martini, F (2012) Palliative sedation in end-of-life care and survival: A systematic review. J Clin Oncol 30: pp. 1378-83 CrossRef
  3. Kirk, TW, Mahon, MM (2010) Palliative Sedation Task Force of the National Hospice and Palliative Care Organization Ethics Committee: National hospice and palliative care organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients. J Pain Symptom Manage 39: pp. 914-23 CrossRef
  4. Cherny, NI, Radbruch, L (2009) Board of the European Association for Palliative Care: European association for palliative care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23: pp. 581-93 CrossRef
  5. Graeff, A, Dean, M (2007) Palliative sedation therapy in the last weeks of life: A literature review and recommendations for standards. J Palliat Med 10: pp. 67-85 CrossRef
  6. Pasman, HR, Wolf, JE, Hesselink, BA, Heide, A, Wal, G, Maas, PJ (2009) Policy statements and practice guidelines for medical end-of-life decisions in Dutch health care institutions: developments in the past decade. HealthPolicy 92: pp. 79-88
  7. Claessens, P, Menten, J, Schotsmans, P, Broeckaert, B (2008) Palliative sedation: A review of the research literature. J Pain Symptom Manage 36: pp. 310-33 CrossRef
  8. Fainsinger, RL, Waller, A, Bercovici, M, Bengtson, K, Landman, W, Hosking, M (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14: pp. 257-65 CrossRef
  9. Feldman, MD, Zhang, J, Cummings, SR (1999) Chinese and U.S. Internists Adhere to Different Ethical Standards. J Gen Intern Med 14: pp. 469-73 CrossRef
  10. Xiaoli, G, Wenwu, C (2010) Palliative sedation for terminally ill cancer patients. China oncology 20: pp. 695-8
  11. Alonso-Babarro, A, Varela-Cerdeira, M, Torres-Vigil, I, Rodríguez-Barrientos, R, Bruera, E (2010) At-home palliative sedation for end-of-life cancer patients. Palliat Med 24: pp. 486-92 CrossRef
  12. Maltoni, M, Pittureri, C, Scarpi, E, Piccinini, L, Martini, F, Turci, P (2009) Palliative sedation therapy does not hasten death: Results from a prospective multicenter study. Ann Oncol 20: pp. 1163-9 CrossRef
  13. Kohara, H, Ueoka, H, Takeyama, H, Murakami, T, Morita, T (2005) Sedation for terminally ill patients with cancer with uncontrollable physical distress. J Palliat Med 8: pp. 20-5 CrossRef
  14. Morita, T, Tsunoda, J, Inoue, S, Chihara, S (2001) Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 21: pp. 282-9 CrossRef
  15. Vitetta, L, Kenner, D, Sali, A (2005) Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliat Care 22: pp. 465-73
  16. Chiu, TY, Hu, WY, Lue, BH, Cheng, SY, Chen, CY (2001) Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 21: pp. 467-72 CrossRef
  17. Krishna, LKR, Poulose, VJ, Goh, C (2012) The use of midazolam and haloperidol in cancer patients at the end of life. Singapore Med J 53: pp. 62-6
  18. Turner, K, Chye, R, Aggarwal, G, Philip, J, Skeels, A, Lickiss, JN (1996) Dignity in dying: A preliminary study of patients in the last three days of life. J
• 刊物主题：Pain Medicine; Quality of Life Research;
• 出版者：BioMed Central
• ISSN：1472-684X

文摘

Background There are a number of studies dedicated to characteristics of sedation, but these studies are mostly bound to western country practices. The aim of this study is to describe the characteristics of patients who suffered from cancer and who had been sedated until their death in Shanghai, China. Methods Retrospective medical data of 244 terminally ill cancer patients including 82 sedated patients were collected. Data collected included demographic characteristics, disease-related characteristics and details of the sedation. Results In sedated cases, patients and/or caregivers gave the consent to start palliative sedation due to unmanageable symptoms. On average, sedation was performed 24.65(±1.78)hours before death. Agitated delirium and dyspnea were the most frequent indications for palliative sedation. There was no significant difference in survival time from admission till death between sedated and non-sedated patients (p--.05). Conclusions Palliative sedation is effective for reducing terminally ill cancer patients-suffering without hastening death. Prospective research is needed to determine the optimal conditions for Chinese patients including indications, decision making process, informed consent, cultural and ethical issues, type of sedation and drugs.